Imperial Innovations receives a €71M loan from the European Investment Bank

16/07/2015 - 2 minutes

Imperial Innovations secured another loan facility from the European Investment Bank (EIB) to support the company’s investments in the UK biotech and life science sector. This €71.3M (£50 million) funding follows a previous €42.9M (£30 million) loan granted by the EIB in July 2013.

The European Investment Bank, which last year provided €13.3Bn to enhance investments and to support innovation, is committed to encourage research investment throughout Europe. This is also valid for the UK, as the EIB’s action demonstrates the strong cooperation between the European organism and Imperial Innovations.

The loan facility is available for a period of two years and is repayable over a maximum nine year period following the date of the first draw down. Russ Cummings, Chief Executive Officer of Imperial Innovations explained that the company has been able to execute the loan plan in just two years, instead of the original four-year period. This success has been achieved thanks to the increasing maturity of Innovations’ portfolio, as well as the rich opportunities derived from its extensive network of academics,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!